Furthermore, while previous studies have implicated NCoR1 in NCSLC tumor growth and survival, this effect can be mediated by its transcriptional repression and association, not only to RAR, but also to other nuclear receptors and specific transcription factors (Noblejas-López et al, 2018; Tan et al, 2019). The gene discussed is NCOR1; the disease is neoplasm.